Biohaven Pharmaceutical Hold
13F holders, Q1 2026 (March 31)1holders −1
0new positions
1sold out
$8.46avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holder was Knoll Capital Management, LLC ($19.7M).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $670K |
All 13F filers, Q4 2025 → Q1 2026: 59,365 shares sold, net −59,365 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Knoll Capital Management, LLC | 10.44% | No change | 2,328,602 | $19.7M |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.